Form D · Biotechnology

CellAegis Devices Inc.

Toronto, A6 · CIK 0001573661

Offering snapshot reported Mar 10, 2017 · SEC filing

Reported sold
$3.11M
Offering amount: $3.11M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 1, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.56M$3.11MMar 9, 2017: $3,114,304.00Mar 9, 2017Mar 10, 2017: $3,114,304.00Mar 10, 2017: $3,114,304.00Mar 10, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 10, 2017Amendment$3,114,304$0vs Mar 10, 20175SEC filing
Mar 10, 2017Amendment$3,114,304$0vs Mar 9, 20175SEC filing
Mar 9, 2017Initial$3,114,304No comparison5SEC filing
Mar 9, 2017Initial$6,400No comparison1SEC filing
Mar 9, 2017Initial$6,386No comparison1SEC filing
Mar 9, 2017Initial$311No comparison1SEC filing
Mar 9, 2017Initial$2,500No comparison1SEC filing
Mar 9, 2017Initial$617No comparison1SEC filing
Mar 9, 2017Initial$13,615No comparison1SEC filing
Mar 9, 2017Initial$385No comparison1SEC filing
Mar 9, 2017Initial$8,650No comparison1SEC filing
May 9, 2016Amendment$81,108$48,608vs Apr 6, 20165SEC filing
Apr 6, 2016Initial$32,500No comparison2SEC filing
Jul 19, 2013Initial$4,947No comparison1SEC filing
Apr 3, 2013Initial$23,693No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-282186

Source: Form D, filed Mar 10, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

I-QU ANDROS HERITAGE LP

Investment adviser: I-QU & CO. MANAGEMENT, L.P.

Gross asset value
$13.1M
Beneficial owners
6
ADV minimum commitment
$0

Reported in Form ADV on Sep 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor PRICEWATERHOUSECOOPERS GRAND CAYMAN, Cayman Islands
Custodian J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK SANTA CLARA, California, United States Related to adviser: No
Prime broker J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

PRICEWATERHOUSECOOPERS
PCAOB 1266

J.P. MORGAN SECURITIES LLC
SEC 8-35008

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 8-35008

Filing source

Form ADV 2132835 · Sep 30, 2026 · Schedule D 7.B.(1), fund 805-5368146387

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Berton Director, Executive
Chris Caldarone Director
Chris Colecchi Director
Rocky Ganske Director, Executive
Henry Kay Director
Eric Knudsen Director
Donna Parr Director, Executive
Andrew Redington Director
Brian Roberts Director
Shermaine Tilley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
139 Mulock Ave., 1 St Floor
Toronto, A6, M6N 1G9